Cargando…

A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus

Lymph- and blood-borne retroviruses exploit CD169/Siglec-1-mediated capture by subcapsular sinus and marginal zone metallophilic macrophages for trans-infection of permissive lymphocytes. However, the impact of CD169-mediated virus capture on retrovirus dissemination and pathogenesis in vivo is unkn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchil, Pradeep D., Pi, Ruoxi, Haugh, Kelsey A., Ladinsky, Mark S., Ventura, John D., Barrett, Brad S., Santiago, Mario L., Bjorkman, Pamela J., Kassiotis, George, Sewald, Xaver, Mothes, Walther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331384/ https://www.ncbi.nlm.nih.gov/pubmed/30595553 http://dx.doi.org/10.1016/j.chom.2018.11.011

Ejemplares similares

In vivo imaging of retrovirus infection reveals a role for Siglec-1/CD169 in multiple routes of transmission
por: Haugh, Kelsey A, et al.
Publicado: (2021)

Murine leukemia virus targets innate-like B1 B cells to establish infection in mice
por: Sewald, Xaver, et al.
Publicado: (2013)

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease
por: Herzog, Silva, et al.
Publicado: (2022)

TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling
por: Lascano, Josefina, et al.
Publicado: (2015)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
por: Ventura, John D., et al.
Publicado: (2019)

SV40 Polyomavirus Activates the Ras-MAPK Signaling Pathway for Vacuolization, Cell Death, and Virus Release
por: Motamedi, Nasim, et al.
Publicado: (2020)

TRIM5 is an innate immune sensor for the retrovirus capsid lattice
por: Pertel, Thomas, et al.
Publicado: (2011)

Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169)
por: Bradford, Barry M, et al.
Publicado: (2014)

Interferon-Inducible Mechanism of Dendritic Cell-Mediated HIV-1 Dissemination Is Dependent on Siglec-1/CD169
por: Puryear, Wendy Blay, et al.
Publicado: (2013)

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients
por: Ostendorf, Lennard, et al.
Publicado: (2021)

TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle
por: Uchil, Pradeep D, et al.
Publicado: (2008)

Porcine Sialoadhesin (CD169/Siglec-1) Is an Endocytic Receptor that Allows Targeted Delivery of Toxins and Antigens to Macrophages
por: Delputte, Peter L., et al.
Publicado: (2011)

SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus
por: von Stuckrad, Sae Lim, et al.
Publicado: (2020)

CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
por: Doehn, Jan-Moritz, et al.
Publicado: (2021)

Functional Characterization of the Putative Hepatitis B Virus Core Protein Late Domain Using Retrovirus Chimeras
por: Garcia, Mayra L., et al.
Publicado: (2013)

CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
por: Lende, Stine Sofie Frank, et al.
Publicado: (2022)

Murine Leukemia Virus Spreading in Mice Impaired in the Biogenesis of Secretory Lysosomes and Ca(2+)-Regulated Exocytosis
por: Chan, Wai-Tsing, et al.
Publicado: (2008)

TRIM5alpha contributes to the anti-viral state
por: Pertel, Thomas, et al.
Publicado: (2009)

Sialoadhesin (CD169/Siglec-1) is an extended molecule that escapes inhibitory cis-interactions and synergizes with other macrophage receptors to promote phagocytosis
por: Klaas, Mariliis, et al.
Publicado: (2023)

Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 “Knockouts” Tell Us About Pathogenesis
por: Martinez-Picado, Javier, et al.
Publicado: (2017)

Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis
por: Young, George R, et al.
Publicado: (2013)

Interaction of the European genotype porcine reproductive and respiratory syndrome virus (PRRSV) with sialoadhesin (CD169/Siglec-1) inhibits alveolar macrophage phagocytosis
por: De Baere, Miet I, et al.
Publicado: (2012)

Cell-to-Cell Transmission Can Overcome Multiple Donor and Target Cell Barriers Imposed on Cell-Free HIV
por: Zhong, Peng, et al.
Publicado: (2013)

Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer
por: Kassiotis, George, et al.
Publicado: (2017)

Resurrection of endogenous retroviruses in antibody-deficient mice
por: Young, George R, et al.
Publicado: (2012)

Retrovirus-Specificity of Regulatory T Cells Is Neither Present nor Required in Preventing Retrovirus-Induced Bone Marrow Immune Pathology
por: Antunes, Inês, et al.
Publicado: (2008)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection
por: Li, Sam X., et al.
Publicado: (2016)

Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy
por: Sewald, Xaver
Publicado: (2018)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Mutation of the Putative Immunosuppressive Domain of the Retroviral Envelope Glycoprotein Compromises Infectivity
por: Eksmond, Urszula, et al.
Publicado: (2017)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Human TRIM Gene Expression in Response to Interferons
por: Carthagena, Laetitia, et al.
Publicado: (2009)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes
por: Li, Wenwei, et al.
Publicado: (2023)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Study of the disintegration of erbium 169
por: Charpak, Georges, et al.
Publicado: (1959)

169th AAS Meeting
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_srcm7gq76s4saqi8kqm5jutja2